Medicare Enrolled
Dr. Violette Henein, M.D.
Rheumatology · Clinton Township, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Henein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Henein?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Henein
Dr. Violette Henein is a rheumatology specialist in Clinton Township, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Henein performed 4,926 Medicare services across 1,033 unique beneficiaries.
Between the years covered by Open Payments, Dr. Henein received a total of $7,464 from 36 pharmaceutical and/or device companies across 406 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Henein is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 26% volume in MI
$7,464 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,926
Medicare services
Top 26% in MI for rheumatology
1,033
Unique beneficiaries
$27
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~259 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,741 | $18 | $25 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
1,678 | $1 | $9 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
505 | $94 | $150 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
208 | $11 | $40 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
131 | $50 | $100 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
112 | $63 | $110 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
73 | $38 | $118 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
65 | $124 | $225 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
64 | $23 | $130 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
60 | $104 | $600 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
57 | $50 | $210 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
54 | $37 | $200 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
51 | $91 | $230 |
| X-ray of hand, minimum of 3 views An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints. |
26 | $30 | $80 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
25 | $134 | $200 |
| Knee X-ray, 3 views An X-ray imaging test of the knee joint that captures three different angles to evaluate the bones and surrounding structures. |
18 | $33 | $80 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
16 | $76 | $100 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
16 | $29 | $30 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
13 | $55 | $156 |
| X-ray of lower and sacral spine, minimum of 4 views An X-ray imaging test of the lower back and sacrum using at least four different angles to visualize the bones and joints. |
13 | $35 | $100 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.4% high complexity
76.2% medium
21.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,464
Total received (2018-2024)
Avg $1,066/year across 7 years
Top 30% in MI for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
406
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,413 (99.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$51 (0.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,645
2023
$2,885
2022
$1,219
2021
$53
2020
$115
2019
$73
2018
$473
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$445
Janssen Biotech, Inc.
$413
UCB, Inc.
$374
PFIZER INC.
$194
ABBVIE INC.
$190
Novartis Pharmaceuticals Corporation
$163
Fresenius Kabi USA, LLC
$160
E.R. Squibb & Sons, L.L.C.
$159
AstraZeneca Pharmaceuticals LP
$94
SOBI, INC
$86
ANI Pharmaceuticals, Inc.
$62
Organon Llc
$52
Lilly USA, LLC
$49
Actelion Pharmaceuticals US, Inc.
$40
Alexion Pharmaceuticals, Inc.
$27
Boehringer Ingelheim Pharmaceuticals, Inc.
$26
Octapharma USA, Inc.
$24
Sandoz Inc.
$22
Biocon Biologics Inc
$22
Kyowa Kirin, Inc.
$21
Radius Health, Inc.
$21
Top 3 companies account for 46.6% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,431
Janssen Biotech, Inc.
$915
UCB, Inc.
$566
Novartis Pharmaceuticals Corporation
$543
Horizon Therapeutics plc
$517
PFIZER INC.
$446
ABBVIE INC.
$391
Lilly USA, LLC
$378
AstraZeneca Pharmaceuticals LP
$370
GlaxoSmithKline, LLC.
$270
E.R. Squibb & Sons, L.L.C.
$260
Fresenius Kabi USA, LLC
$245
Boehringer Ingelheim Pharmaceuticals, Inc.
$103
SOBI, INC
$86
Sandoz Inc.
$83
Aurinia Pharma U.S., Inc.
$77
Genentech USA, Inc.
$69
AbbVie, Inc.
$64
Organon LLC
$62
ANI Pharmaceuticals, Inc.
$62
Organon Llc
$52
Alexion Pharmaceuticals, Inc.
$45
Radius Health, Inc.
$43
GENZYME CORPORATION
$41
Biocon Biologics Inc
$40
Actelion Pharmaceuticals US, Inc.
$40
ASCEND Therapeutics US, LLC
$38
Regeneron Healthcare Solutions, Inc.
$37
Mylan Institutional Inc.
$37
Celltrion USA Inc.
$31
Alvogen Inc
$26
Octapharma USA, Inc.
$24
Kyowa Kirin, Inc.
$21
AbbVie Inc.
$20
Ferring Pharmaceuticals Inc.
$16
West-Ward Pharmaceuticals
$13
Top 3 companies account for 39.0% of all-time payments
Associated products mentioned in payments ›
AMJEVITA · Actemra · BENLYSTA · BINOSTO · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Crysvita · DUEXIS · EUFLEXXA · EVENITY · Enbrel · HADLIMA · HYRIMOZ · Hulio · Humira · IDACIO · ILARIS · KEVZARA · KEVZARA SARILUMAB INJECTION · KINERET · KRYSTEXXA · LUPKYNIS · Mitigare · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPSUMIT · ORENCIA · Otezla · PENNSAID · PURIFIED CORTROPHIN GEL · REMICADE · RENFLEXIS · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · Tavneos · Tymlos · VIMOVO · XELJANZ · YUFLYMA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Rheumatologists within 10 mi
55
Per 100K population
6.3
County median income
$76,399
Nearest hospital
HENRY FORD MACOMB HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Henein is a clinical cardiology specialist, with above-average Medicare volume (top 26% in MI), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Henein experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Henein performed 1,741 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Henein receive payments from pharmaceutical companies?
Yes. Dr. Henein received a total of $7,464 from 36 companies across 406 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Henein's costs compare to other rheumatologists in Clinton Township?
Dr. Henein's average Medicare payment per service is $27. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Henein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Clinton Township
Browse rheumatologists in Clinton Township ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in MI
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in MI
Which MI rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology